Category - Pharma Industry News
STAT+: Eli Lilly opens a new legal front in its battle against compounded GLP-1s
As Trump Threatens Pharmaceutical Tariffs, India’s Drug Makers Shudder
Bring Out Your Meds! To the Feds!
Over half of U.S. counties have no system in place for monitoring air quality
Industry Outlook 2025: The Impact of Politics on Pharma
STAT+: Pharmalittle: We’re reading about Lilly strategy against compounders, Bristol’s antipsychotic, and more
Roche to Invest $50 Billion in US Pharmaceuticals and Diagnostics
Where Does Rare Disease and Patient-Focus Fall into Commissioner Makary’s Priorities & the MAHA Platform for FDA? A New Ultrarare Approval Pathway & More